DEF 14A

Company

INOVIO PHARMACEUTICALS, INC.

Filed

March 29, 2017

Period of Report

March 17, 2017

Accession Number

0001055726-17-000019

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →